{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:39:47Z","timestamp":1775641187392,"version":"3.50.1"},"reference-count":210,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.cld.2004.11.004","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T17:29:14Z","timestamp":1113845354000},"page":"103-134","source":"Crossref","is-referenced-by-count":32,"title":["Treatment of Alcoholic Hepatitis"],"prefix":"10.1016","volume":"9","author":[{"given":"Robert S.","family":"O'Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2004.11.004_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib2","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"issue":"8981","key":"10.1016\/j.cld.2004.11.004_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(95)91685-7","article-title":"Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver","volume":"346","author":"Teli","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2004.11.004_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-9343(68)90111-3","article-title":"Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease","volume":"44","author":"Powell","year":"1968","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib5","first-page":"303","article-title":"Pathological spectrum of alcoholic liver disease","volume":"2","author":"Hall","year":"1994","journal-title":"Alcohol Alcohol Suppl"},{"issue":"suppl 1","key":"10.1016\/j.cld.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-8278(21)80001-X","article-title":"Alcoholic liver disease: pathobiological aspects","volume":"23","author":"Lindros","year":"1995","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"10.1016\/j.cld.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.mam.2004.02.019","article-title":"Oxidative stress and antioxidant defenses in ethanol-induced cell injury","volume":"25","author":"Koch","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.cld.2004.11.004_bib8","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1053\/gast.2001.24051","article-title":"Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease","volume":"120","author":"Degoul","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2004.11.004_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03401845","article-title":"Genetic determinants of ethanol-induced liver damage","volume":"7","author":"Monzoni","year":"2001","journal-title":"Mol Med"},{"key":"10.1016\/j.cld.2004.11.004_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.41.6.845","article-title":"Drinking habits as cofactors of risk for alcohol induced liver damage","volume":"41","author":"Bellentani","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cld.2004.11.004_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2007-1007267","article-title":"Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease","volume":"15","author":"Koff","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2004.11.004_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/jhep.2003.50275","article-title":"Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C","volume":"38","author":"Rigamonti","year":"2003","journal-title":"Hepatology"},{"issue":"5 suppl 1","key":"10.1016\/j.cld.2004.11.004_bib13","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1002\/hep.1840360728","article-title":"Alcohol use and hepatitis C","volume":"36","author":"Peters","year":"2002","journal-title":"Hepatology"},{"issue":"4 suppl","key":"10.1016\/j.cld.2004.11.004_bib14","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1111\/j.1530-0277.2000.tb00024.x","article-title":"Contribution of hepatitis C virus to the progression of alcoholic liver disease","volume":"24","author":"Tanaka","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2004.11.004_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.2003.01546.x","article-title":"Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study","volume":"17","author":"Hezode","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2004.11.004_bib17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/00365529509101616","article-title":"Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlations to liver disease","volume":"30","author":"Befrits","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0168-8278(05)80659-2","article-title":"A prospective study of alcoholic liver disease and mortality","volume":"16","author":"Bouchier","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib19","first-page":"210","article-title":"Prognostic factors in alcoholic liver disease","volume":"86","author":"Chedid","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/jlts.1997.v3.ajlts0030206","article-title":"Alcoholic liver disease: natural history","volume":"3","author":"Diehl","year":"1997","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.cld.2004.11.004_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0016-5085(87)90861-4","article-title":"Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis","volume":"92","author":"Orrego","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib22","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF01536804","article-title":"Prognostic signficance of cholestatic alcoholic hepatitis","volume":"35","author":"Nissenbaum","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2004.11.004_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0016-5085(19)33180-4","article-title":"Natural history of alcoholic hepatitis: III. Histological changes","volume":"63","author":"Galambos","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the esophagus for bleeding varices","volume":"60","author":"Pugh","year":"1983","journal-title":"Br J Surg"},{"key":"10.1016\/j.cld.2004.11.004_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/hep.1840030602","article-title":"Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity","volume":"3","author":"Orrego","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-2008-1040531","article-title":"Alcoholic hepatitis: clinicopathologic features and therapy","volume":"8","author":"Maddrey","year":"1988","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2004.11.004_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib30","first-page":"291","article-title":"Clinical forms and prognostic criteria in alcoholic hepatitis","volume":"6","author":"Garcia","year":"1989","journal-title":"Med Int"},{"key":"10.1016\/j.cld.2004.11.004_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1530-0277.1996.tb01813.x","article-title":"Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression","volume":"20","author":"Kumashiro","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-8278(86)80006-X","article-title":"Histological course of alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage","volume":"2","author":"Pares","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(05)80489-1","article-title":"The prognosis of patients with alcoholic liver disease: an international randomized placebo-controlled trial on the effects of malotilate on survival","volume":"20","author":"Keiding","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib34","first-page":"1","article-title":"Plasma vitamin B12 titres as indicators of disease severity and mortality of patients with alcoholic hepatitis","volume":"22","author":"Baker","year":"1987","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cld.2004.11.004_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0676.1994.tb00053.x","article-title":"The arterial blood ketone body ratio as a possible marker of multi-organ failure in patients with alcoholic hepatitis","volume":"14","author":"Saibara","year":"1994","journal-title":"Liver"},{"key":"10.1016\/j.cld.2004.11.004_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib37","first-page":"55","article-title":"Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis","volume":"27","author":"Pereira","year":"1992","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cld.2004.11.004_bib38","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/0016-5085(86)90253-2","article-title":"Significance of megamitochondria in alcoholic liver disease","volume":"90","author":"Chedid","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased tumor necrosis factor in severe alcoholic hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib40","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb00012.x","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance","volume":"24","author":"Fujimoto","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib41","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1111\/j.1530-0277.1999.tb04531.x","article-title":"Prognostic factors in severe alcoholic liver injury","volume":"23","author":"Fujimoto","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2004.04.028","article-title":"Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis","volume":"41","author":"Spahr","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0168-8278(00)80391-8","article-title":"Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis","volume":"32","author":"Castera","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(03)00184-3","article-title":"Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease","volume":"39","author":"Nojgaard","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib45","first-page":"547","article-title":"Increased plasma interleukin-6 concentrations in alcoholic hepatitis","volume":"119","author":"Hill","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.cld.2004.11.004_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0168-8278(97)80042-6","article-title":"Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity","volume":"26","author":"Douds","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00007611-199102000-00036","article-title":"High mortality among patients with the leukemoid reaction and alcoholic hepatitis","volume":"84","author":"Mitchell","year":"1991","journal-title":"South Med J"},{"key":"10.1016\/j.cld.2004.11.004_bib48","doi-asserted-by":"crossref","first-page":"383A","DOI":"10.1111\/j.1530-0277.1996.tb01813.x","article-title":"Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression","volume":"20","author":"Kumashiro","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.1840120213","article-title":"Predictive value of whole blood chemiluminescence in patients with alcoholic hepatitis","volume":"12","author":"Lunel","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib50","series-title":"Diseases of the liver","first-page":"669","article-title":"Alcoholic hepatitis","author":"Mendenhall","year":"1987"},{"key":"10.1016\/j.cld.2004.11.004_bib51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.510250208","article-title":"Neural networks as predictors of outcomes in alcoholic patients with severe liver disease","volume":"25","author":"Lapuerta","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib52","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0016-5085(81)90249-3","article-title":"Continued heavy drinking and survival in alcoholic cirrhotics","volume":"80","author":"Borowsky","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.15.1.52","article-title":"Studies in alcoholic liver disease in Britain","volume":"15","author":"Brunt","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.cld.2004.11.004_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0016-5085(91)80029-9","article-title":"The role of continued drinking in loss of portal perfusion after distal splenorenal shunt","volume":"100","author":"Kawasaki","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-9343(68)90111-3","article-title":"Duration of survival in La\u00ebnnec's cirrhosis","volume":"44","author":"Powell","year":"1968","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0016-5085(97)70104-5","article-title":"Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol","volume":"113","author":"Clot","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib57","first-page":"353","article-title":"Antibodies against ethanol-derived protein adducts: pathogenetic implications","volume":"113","author":"Israel","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/gast.1997.v112.pm9024302","article-title":"Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease","volume":"112","author":"Ma","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0891-5849(01)00742-0","article-title":"Role of malondialdehyde-acetaldehyde adducts in liver injury","volume":"32","author":"Tuma","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cld.2004.11.004_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/mol.55.2.223","article-title":"Autoantibodies against cytochromes P-450E1 and P4503A in alcoholics","volume":"55","author":"Lytton","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.cld.2004.11.004_bib61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/gut.23.3.221","article-title":"Liver membrane antibodies in alcoholic liver disease: 1. Prevalence and immunoglobulin class","volume":"23","author":"Burt","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.cld.2004.11.004_bib62","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.1840190308","article-title":"Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease","volume":"19","author":"Adams","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.510230223","article-title":"Cytokine-induced neutrophil chemoattractant release from hepatocytes is moduled by kupffer cells","volume":"23","author":"Mawet","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2007-1007347","article-title":"Cytokines and alcoholic liver disease","volume":"13","author":"McClain","year":"1993","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2004.11.004_bib65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1746.1995.tb01790.x","article-title":"Role of endotoxin in the hepatic microvascular inflammatory response to ethanol","volume":"10","author":"McCuskey","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of Interleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Natural history and evaluation of prednisolone therapy","volume":"74","author":"Helman","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib68","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197106172842404","article-title":"Corticosteroid therapy in severe alcoholic hepatitis","volume":"284","author":"Porter","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":"Prednisone therapy of acute alcoholic hepatitis","volume":"79","author":"Campra","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib70","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01072499","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis: a prospective, double-blind randomized study","volume":"22","author":"Blitzer","year":"1977","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.cld.2004.11.004_bib71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib73","first-page":"443","article-title":"A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis","volume":"69","author":"Shumaker","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib75","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.cld.2004.11.004_bib76","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long- term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib77","first-page":"769","article-title":"Traitement de l'h\u00e9patite alcoolique aigu\u00eb par la prednisolone","volume":"16","author":"Bories","year":"1987","journal-title":"Presse Med"},{"key":"10.1016\/j.cld.2004.11.004_bib78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methyiprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib79","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib80","first-page":"223","article-title":"Place de la corticoth\u00e9rapie dans le traitement des h\u00e9patites alcooliques aigu\u00ebs. R\u00e9sultats dune m\u00e9taanalyse","volume":"15","author":"Daures","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cld.2004.11.004_bib81","first-page":"208","article-title":"Treatment of alcoholic hepatitis","volume":"2","author":"Reynolds","year":"1989","journal-title":"Gastroenterol Int"},{"key":"10.1016\/j.cld.2004.11.004_bib82","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis?","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cld.2004.11.004_bib84","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib85","first-page":"108","article-title":"Severe acute alcoholic hepatitis: an audit of medical treatment","volume":"95","author":"O'Keefe","year":"2002","journal-title":"Ir Med J"},{"key":"10.1016\/j.cld.2004.11.004_bib86","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib87","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00365521.1976.12097111","article-title":"Alcoholic hepatitis superimposed on cirrhosis, clinical significance of long term prednisone treatment","volume":"22","author":"Schichting","year":"1976","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib88","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gut.19.12.1131","article-title":"Oral prednisone for chronic active liver disease: dose response and bioavailability studies","volume":"19","author":"Uribe","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.cld.2004.11.004_bib89","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199510193331607","article-title":"Medical disorders of alcoholism","volume":"333","author":"Lieber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib90","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.510230516","article-title":"Does malnutrition affect survival in cirrhosis","volume":"23","author":"Merli","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","article-title":"Protein calorie malnutrition associated with alcoholic hepatitis","volume":"76","author":"Mendenhall","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2008-1040445","article-title":"Disordered energy and protein metabolism in liver disease","volume":"11","author":"McCullough","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2004.11.004_bib93","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.1840190234","article-title":"Nutritional supplementation in chronic liver disease: an analytical review","volume":"19","author":"Nomnpleggi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib94","first-page":"871","article-title":"A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis","volume":"82","author":"Achord","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib95","first-page":"1200","article-title":"A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone: I. Short-term effects on liver function","volume":"86","author":"Bonkovsky","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hep.1840050114","article-title":"Effect of parenteral amino acid supplementation in alcoholic hepatitis","volume":"5","author":"Diehl","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib97","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs Cooperative Study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib98","first-page":"1275","article-title":"Amino acid therapy of alcoholic hepatitis","volume":"2","author":"Nasrallah","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2004.11.004_bib99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(88)80483-5","article-title":"A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis","volume":"7","author":"Simon","year":"1988","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(90)90293-A","article-title":"Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial","volume":"98","author":"Cabre","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib101","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.1840140624","article-title":"Effects of parenteral amino acid supplementation on short term and long term outcomes in severe alcoholic hepatitis: a randomized controlled trial","volume":"14","author":"Mezey","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy: comparison of prednisolone with caloric supplements","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib103","first-page":"535","article-title":"Hyperalimentation in alcoholic hepatitis","volume":"72","author":"Galambos","year":"1979","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib104","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0148607185009005590","article-title":"VA Cooperative study on alcoholic hepatitis III: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy","volume":"9","author":"Mendenhall","year":"1985","journal-title":"J Parenteral Enteral Nutr"},{"key":"10.1016\/j.cld.2004.11.004_bib105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep.1840060219","article-title":"A randomized clinical trial of supplementary parenteral nutrion in jaundiced alcoholic cirrhotic patients","volume":"6","author":"Naveau","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/hep.1840070606","article-title":"Metabolic effects of enteral formula feeding in alcoholic hepatitis","volume":"7","author":"Soberon","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(92)91801-A","article-title":"Accelerated improvement of alcoholic liver disease with enteral nutrition","volume":"102","author":"Kearns","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib108","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in a malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib109","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(85)80762-5","article-title":"Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis","volume":"1","author":"Calvey","year":"1985","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib111","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0016-5085(01)83918-4","article-title":"Nutritional therapy for alcoholic hepatitis: new life for an old idea","volume":"120","author":"Foody","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib112","series-title":"The A.S.P.E.N. nutrition support practice manual","first-page":"l","article-title":"Guidelines for nutritional therapy in liver disease","author":"McCullough","year":"1998"},{"key":"10.1016\/j.cld.2004.11.004_bib113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0261-5614(97)80022-2","article-title":"ESPEN guidelines for nutrition in liver disease and transplantation","volume":"16","author":"Plauth","year":"1997","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cld.2004.11.004_bib114","first-page":"169","article-title":"Nutritional management of acute and chronic liver disease","volume":"13","author":"Florez","year":"2002","journal-title":"Semin Gastrointest Dis"},{"key":"10.1016\/j.cld.2004.11.004_bib115","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/gast.1997.v112.pm9178701","article-title":"Differential inhibition of epidermal growth factor signaling pathways in rat hepatocytes by long-term ethanol treatment","volume":"112","author":"Saso","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib116","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0016-5085(90)90631-A","article-title":"Ethanol inhibits liver regeneration in rats without reducing transcripts of key protooncogenes","volume":"99","author":"Diehl","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib117","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(94)92025-7","article-title":"Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis","volume":"343","author":"Fang","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2004.11.004_bib118","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jss.2003.10.026","article-title":"Molecular and cellular features of hepatic regeneration","volume":"117","author":"Black","year":"2004","journal-title":"J Surg Res"},{"key":"10.1016\/j.cld.2004.11.004_bib119","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.hep.2003.09.034","article-title":"Transcription factor sin liver development, differentiation and regeneration","volume":"38","author":"Costa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1440-1746.2003.02906.x","article-title":"Oval cell-mediated liver regeneration: role of cytokines and growth factors","volume":"18","author":"Lowes","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib121","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcholic hepatitis by infusion of insulin and glucagon : a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib122","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.1840140625","article-title":"Insulin and glucagons infusion in acute alcoholic hepatitis: a prospective randomized controlled trial","volume":"14","author":"Bird","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib123","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0016-5085(81)90250-X","article-title":"A randomized clinical trial of insulin and glucagons infusion for treatment of alcoholic hepatitis: progress report in 50 patients","volume":"80","author":"Baker","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib124","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0168-8278(87)80577-9","article-title":"A prospective multicenter study of insulin and glucagons infusion therapy in acute alcoholic hepatitis","volume":"5","author":"Feher","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02774333","article-title":"A multi-centre double blind controlled trial of glucagons and insulin therapy for severe acute hepatitis","volume":"24","author":"Oka","year":"1989","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.cld.2004.11.004_bib126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/cs0940219","article-title":"Epidermal growth factor protects against carbon tetrachloride-induced hepatic injury","volume":"94","author":"Berlanga","year":"1998","journal-title":"Clin Sci (Colch)"},{"key":"10.1016\/j.cld.2004.11.004_bib127","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1248\/bpb.23.1243","article-title":"Hepatoprotection by human epidermal growth factor (hEGF) against experimental hepatitis induced by D-galactosamine (D-galN) or D-GalN\/lipopolysaccharide","volume":"23","author":"Cho","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.cld.2004.11.004_bib128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1172\/JCI4433","article-title":"Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats","volume":"103","author":"Tahara","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2004.11.004_bib129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.510300102","article-title":"Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice","volume":"30","author":"Kosai","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0168-8278(96)80157-7","article-title":"Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis","volume":"24","author":"Hillan","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib131","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(94)92025-7","article-title":"Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis","volume":"343","author":"Fang","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2004.11.004_bib132","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0168-8278(87)80040-5","article-title":"Effects of malotilate on ethanol-inhibited hepatocyte regeneration in rats","volume":"5","author":"Takada","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib133","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0016-5085(88)90565-3","article-title":"Liver hypermetabolism during alcohol withdrawal in humans","volume":"94","author":"Hadengue","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib134","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0016-5085(85)80003-2","article-title":"Oxygen supply to the liver in patients with alcoholic liver diseases assessed by organ-reflectance spectrophotometry","volume":"88","author":"Hayashi","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib135","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1073\/pnas.72.3.1137","article-title":"Experimental alcohol induced hepatic necrosis: suppression by propylthiouracil","volume":"72","author":"Israel","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cld.2004.11.004_bib136","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2362.1980.tb00022.x","article-title":"Hepatic vein oxygenation, liver blood flow and the rate of ethanol metabolism in recently abstinent alcoholic patients","volume":"10","author":"Iturriaga","year":"1980","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cld.2004.11.004_bib137","first-page":"846","article-title":"Hepatic circulation and hepatic oxygen consumption in alcoholic and non alcoholic fatty liver","volume":"83","author":"Kasahara","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib138","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI103010","article-title":"The hepatic blood flow and splanchnic oxygen consumption in alcoholic fatty liver","volume":"33","author":"Kessler","year":"1954","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2004.11.004_bib139","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(79)80137-7","article-title":"Thyroid hormones in alcoholic liver disease: effect of treatment with 6-n-propylthiouracil","volume":"76","author":"Israel","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(79)80136-5","article-title":"Effect of short term therapy with PTU in patients with alcoholic liver disease","volume":"76","author":"Orrego","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib141","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"87","author":"Halle","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib142","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0676.2001.210606.x","article-title":"Meta-analysis of propylthiouracil for alcoholic liver disease\u2014a Cochrane Hepatobiliary group review","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.cld.2004.11.004_bib143","first-page":"695","article-title":"Treatment of cirrhosis of the liver with testosterone propionate","volume":"9","author":"Rosenak","year":"1947","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib144","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00005792-196209000-00003","article-title":"Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature","volume":"41","author":"Leevy","year":"1962","journal-title":"Medicine"},{"key":"10.1016\/j.cld.2004.11.004_bib145","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0149-2918(01)80114-4","article-title":"A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids","volume":"23","author":"Shahidi","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.cld.2004.11.004_bib146","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200464070-00004","article-title":"The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders","volume":"64","author":"Orr","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.cld.2004.11.004_bib147","first-page":"93","article-title":"The effect of testosterone on liver healing after partial hepatectomy","volume":"127","author":"Bengmark","year":"1964","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.cld.2004.11.004_bib148","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840060535","article-title":"Is therapy with testosterone or anabolic-androgenic steroids useful in the treatment of alcoholic liver disease?","volume":"6","author":"Maddrey","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib149","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-65-4-738","article-title":"The nonefficacy of short term anabolic steroid therapy in alcoholic liver disease","volume":"65","author":"Fenster","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2004.11.004_bib150","first-page":"1100","article-title":"Risk factors and therapy in alcoholic hepatitis (AH)","volume":"72","author":"Mendenhall","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib151","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib152","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.1840060502","article-title":"Testosterone treatment of men with alcoholic cirrhosis: a double-blind study","volume":"6","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib153","first-page":"1200","article-title":"A randomized controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I Short term effects on liver function","volume":"86","author":"Bonkovsky","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib154","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200464070-00004","article-title":"The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety","volume":"64","author":"Orr","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.cld.2004.11.004_bib155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs Cooperative Study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib156","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review","volume":"97","author":"Rambaldi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib157","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0168-8278(05)80181-3","article-title":"Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation","volume":"19","author":"Poo","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib158","first-page":"G707","article-title":"Effect of colchicine on the clearance of ferritin in vivo","volume":"258","author":"Ramm","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cld.2004.11.004_bib159","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0168-8278(88)80051-5","article-title":"Protective effect of colchicine on acute liver damage induced by carbon tetrachloride","volume":"6","author":"Mourelle","year":"1988","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90973-5","article-title":"Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis","volume":"99","author":"Akriviadis","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib161","first-page":"551","article-title":"Treatment of alcoholic hepatitis with colchicine. Results of a randomized double-blind trial","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cld.2004.11.004_bib162","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-0676.2001.021002129.x","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.cld.2004.11.004_bib163","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1530-0277.1993.tb00798.x","article-title":"Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration","volume":"17","author":"Barak","year":"1993","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib164","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.1840110203","article-title":"S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon","volume":"11","author":"Lieber","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0016-5085(94)95023-7","article-title":"Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon","volume":"106","author":"Lieber","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib166","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0741-8329(02)00224-0","article-title":"S-Adenosymethionine, cytokines, and alcoholic liver disease","volume":"27","author":"McClain","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.cld.2004.11.004_bib167","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0741-8329(02)00232-X","article-title":"Role of S-adenosyl L methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium","volume":"27","author":"Purohit","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.cld.2004.11.004_bib168","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.ALC.0000108654.77178.03","article-title":"Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis","volume":"28","author":"Lee","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib169","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized placebo-controlled double blind multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib170","article-title":"S-adenosyl-L-methionine for alcoholic liver disease","volume":"3","author":"Rambaldi","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2004.11.004_bib171","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0741-8329(02)00230-6","article-title":"A-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings","volume":"27","author":"Lieber","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.cld.2004.11.004_bib172","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.1840100322","article-title":"Current status of calcium in hepatocyte injury","volume":"10","author":"Thomas","year":"1989","journal-title":"Hepatalogy"},{"key":"10.1016\/j.cld.2004.11.004_bib173","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00007890-199007000-00003","article-title":"Prevention of early graft failure by the calcium channel blocker nisoldipine: involvement of Kupffer cells","volume":"50","author":"Takei","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2004.11.004_bib174","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/hep.510240217","article-title":"Niodipine, a dihydopyridine type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat","volume":"24","author":"Imuro","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomized controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib176","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0016-5085(94)96015-1","article-title":"Prevention of alcohol-induced hepatic fibrosis by phosphatidylcholine","volume":"106","author":"Mezey","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib177","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.1840120621","article-title":"Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin","volume":"12","author":"Lieber","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib178","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.1840110203","article-title":"S-Adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon","volume":"11","author":"Lieber","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib179","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1530-0277.1997.tb03776.x","article-title":"Polyenylphospatidylcholine decreases alcohol-induced oxidative stress in the baboon","volume":"21","author":"Lieber","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/alcalc\/agg066","article-title":"Polyenylphospatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring S-adenosylmethionine","volume":"38","author":"Aleynik","year":"2003","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cld.2004.11.004_bib181","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","article-title":"Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib182","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/jhep.2001.27445","article-title":"Complementary and alternative medicine in chronic liver disease","volume":"34","author":"Seeff","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib183","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00004836-200310000-00002","article-title":"Is silymarin hepatoprotective in alcoholic liver disease?","volume":"37","author":"Berger","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib184","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of silymarin in the treatment of liver diseases","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.cld.2004.11.004_bib185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00004836-200310000-00013","article-title":"Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons","volume":"37","author":"Lieber","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib186","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib187","first-page":"120","article-title":"Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cld.2004.11.004_bib188","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib189","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib191","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/01.ALC.0000078607.32247.9D","article-title":"Severe alcoholic hepatitis successfully treated by leukocytapharesis: a case report","volume":"27","author":"Tsuji","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2004.11.004_bib192","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/jlts.1997.v3.ajlts0030240","article-title":"Survival and quality of life after liver transplantation for acute alcoholic hepatitis","volume":"3","author":"Shakil","year":"1997","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.cld.2004.11.004_bib193","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/qjmed\/86.10.649","article-title":"Managing severe alcoholic hepatitis complicated by renal failure","volume":"86","author":"Mutimer","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.cld.2004.11.004_bib194","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0168-8278(02)00047-8","article-title":"Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease","volume":"36","author":"Tome","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib195","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0168-8278(02)00086-7","article-title":"Is liver transplantation an appropriate treatment for acute alcoholic hepatitis?","volume":"36","author":"Lucey","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib196","first-page":"753","article-title":"Phospodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor \u03baB and nuclear factor of activated T cells activation","volume":"299","author":"Jiminez","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cld.2004.11.004_bib197","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00042737-199701000-00009","article-title":"Pentoxifylline, a drug with rheological effects, decreases portal pressure in an experimental model of cirrhosis","volume":"9","author":"Sanchez","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib198","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/cs0910029","article-title":"Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis","volume":"91","author":"Soupison","year":"1996","journal-title":"Clin Sci (Colch)"},{"key":"10.1016\/j.cld.2004.11.004_bib199","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akrivadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib201","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib202","first-page":"A698","article-title":"Open label pilot study of the effects of a chimeric anti-tumor necrosis factor monoclonal antibody in patients with severe acute alcoholic hepatitis","volume":"A2105","author":"Fong","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib203","first-page":"S1137","article-title":"A double blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"126","author":"Naveau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2004.11.004_bib204","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib205","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/hep.20267","article-title":"Infliximab and prednisolone: too much of a good thing?","volume":"39","author":"McClain","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib206","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.1840170620","article-title":"Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumour necrosis factor-alpha","volume":"17","author":"Akerman","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2004.11.004_bib207","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2004.11.004_bib208","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0168-8278(00)00047-7","article-title":"Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis","volume":"34","author":"Ziol","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib209","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0168-8278(00)00089-1","article-title":"Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis","volume":"34","author":"Natori","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2004.11.004_bib210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0168-8278(00)00110-0","article-title":"Apoptosis in alcoholic hepatitis: a novel therapeutic target?","volume":"34","author":"Day","year":"2001","journal-title":"J Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326104001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326104001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:17:50Z","timestamp":1735672670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326104001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":210,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1089326104001217"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2004.11.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}